Emergent's CEO says vibe coding faces two big risks: software quality and AI agents replacing traditional apps.
These entrants are competing with far bigger players, including OpenAI, Anthropic, and Microsoft, that make their own ...
Mr. Fowler currently is chair of the board of trustees of the University of Virginia Darden School Foundation. Previously, he spent 14 years at Wells Fargo Securities in senior leadership roles, ...
Maryland-based Emergent BioSolutions has worked its way to the front lines of the COVID-19 vaccine manufacturing field with a suite of deals to produce U.S. supply. But Emergent has more on its mind ...
Quality control errors led millions of potential vaccines to be ruined. For Emergent BioSolutions, Feb. 8 was a day to revel in their success -- at least as far as the public was concerned. Standing ...
Emergent Method has announced that experienced creative leader Brian von Schulz has joined the firm as creative manager, deepening the ...
Emergent Biosolutions shares plunged after the Covid vaccine maker and federal government "mutually agreed" to cancel its multimillion-dollar contract. It was awarded a $628 million U.S. government ...
Emergent BioSolutions is back in focus after analysts cut their price target from $15 to $12, prompting a fresh look at what is and is not working in the story. Bulls view the new $12 mark as a reset ...
The FDA asked Emergent BioSolutions to temporarily stop producing materials for Covid-19 vaccines while U.S. regulators investigate its plant in Baltimore responsible for ruining millions of J&J, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results